While pediatric patients under anti-TNF treatment, particularly those with CD and juvenile idiopathic arthritis [67], are considered at risk for severe TB, a systematic review and meta-analysis by Kedia et al. on adult IBD patients suggests that TB risk correlates more closely with local TB prevalence than with specific treatment regimens [68]. This evidence concerns the gene TNF and inflammatory bowel disease.